Hypertension Linked to Increased Risk for Severe COVID-19
THURSDAY, Nov. 10, 2022 (HealthDay News) — Hypertension is a risk factor for severe COVID-19, with a dose-response relationship for elevated systolic blood pressure (SBP) with severe COVID-19, according to a study published online Nov. 9 in PLOS ONE….
Learn MoreFor Pregnant Women and Their Newborns, COVID Vaccine Offers Better Protection Than Prior Infection
THURSDAY, Nov. 10, 2022 (HealthDay News) – Getting vaccinated for COVID-19 while pregnant provides higher levels of antibodies for both mom and baby than catching the virus does, a new study finds.When pregnant women received one of the two available …
Learn MoreInfants Less Likely Than Other Household Members to Get COVID-19
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — Infants whose mothers test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tend to develop less severe symptoms than their mothers or other members of their household and may not be…
Learn MoreEl motivo de que los pacientes en ventiladores a veces tarden semanas en recuperar la conciencia
MARTES, 8 de noviembre de 2022 (HealthDay News) — Aunque los pacientes con COVID a quienes se saca de los ventiladores pueden tardar cierto tiempo en recuperar la conciencia, un nuevo estudio sugiere que esto no es necesariamente un mal augurio.Más b…
Learn MoreMyocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American Colle…
Learn MoreMyocarditis Up After Second Dose of mRNA-1273 Versus BNT162b2
WEDNESDAY, Nov. 9, 2022 (HealthDay News) — The rates of myocarditis and pericarditis are increased after receipt of the second dose of mRNA-1273 versus BNT162b2, according to a study published in the Nov. 15 issue of the Journal of the American Colle…
Learn MorePaxlovid reduce el riesgo de COVID prolongada
LUNES, 7 de noviembre de 2022 (HealthDay News) — La pastilla antiviral Paxlovid no solo reduce las hospitalizaciones y las muertes tras contraer la COVID-19: una nueva investigación muestra que también reduce las probabilidades de COVID prolongada en…
Learn MoreWhy Patients on Ventilators May Take Weeks to Regain Consciousness
TUESDAY, Nov. 8, 2022 (HealthDay News) — While it can take some time for COVID patients who are taken off ventilators to regain consciousness, a new study suggests this is not necessarily a bad omen.Instead, it might be the way the body protects the …
Learn MoreSecond, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
MONDAY, Nov. 7, 2022 (HealthDay News) — Exposure to a second or third dose of COVID-19 vaccine is associated with an increased risk for relapse for adults with glomerular disease, according to a study published online Nov. 3 in the Journal of the Ame…
Learn MoreUn estudio de Pfizer encuentra un gran aumento en la inmunidad con el refuerzo contra la COVID
VIERNES, 4 de noviembre de 2022 (HealthDay News) — Es probable que ponerse un refuerzo actualizado contra la COVID-19 aumente la protección de forma sustancial, según un nuevo estudio, publicado por la compañía farmacéutica Pfizer el viernes.La notic…
Learn More